Simonetti A

1 paper

ArticleKetamine

Reduction in Cognitive Symptoms Following Intranasal Esketamine Administration in Patients With Chronic Treatment-resistant Depression: A 12-Week Case Series.

Pepe M, Bartolucci G, Marcelli I +4